Click here to register

Join us April 17, 2024 @ 11 AM EDT

Anders Magnusson, Senior Engineer at FUJIFILM Diosynth Biotechnologies will speak on De-Risking the Aseptic Drug-Filling Process and Optimizing Production

The aseptic drug-filling process for biotherapeutics presents significant risk that can impact cost, timeline, approval, and the commercial lifecycle.

Neglecting to thoroughly assess these risks could lead to heightened chances of contamination and errors during production. Without the implementation of effective contamination control strategies, your company may find it challenging to meet regulatory compliance standards, putting the safety and effectiveness of your products at risk.

Understanding the risks associated with the aseptic drug-filling process is essential for pharmaceutical companies aiming to optimize production efficiency. By leveraging scientific Drug Product experience and adopting a proactive approach supported by quality risk management systems, drug developers can ensure the manufacture of safe products that meet regulatory requirements.

Key Learning Objectives:

-Gain valuable insights into enhancing the efficiency and reliability of the drug product manufacturing process

-Learn innovative strategies and best practices from industry experts, empowering you to refine your pharmaceutical production methods

-Explore the seamless integration of drug product development within the biopharmaceutical lifecycle

Don’t miss this opportunity to stay ahead in the ever-evolving landscape of biopharmaceutical manufacturing.